Assura PLC Scrip dividend declaration (9325M)
January 14 2019 - 2:00AM
UK Regulatory
TIDMAGR
RNS Number : 9325M
Assura PLC
14 January 2019
14 January 2019
Assura plc
Scrip Dividend Declaration
Assura plc ("Assura" or "the Company"), the UK's leading primary
care property investor and developer, today announces that,
pursuant to its Scrip Dividend Scheme and in response to the scrip
dividend alternative for the quarterly interim dividend payable on
16 January 2019 (the "Scrip Dividend Alternative"), elections were
received in respect of 14 per cent. of the Company's ordinary
shares in issue as at the record date of 14 December 2019.
Electing shareholders will receive ordinary shares in the
Company ("Shares") in lieu of cash in respect of this dividend and,
accordingly 4,195,055 Shares (the "New Shares") will be issued by
the Company to such shareholders.
Application has therefore been made for the admission of the New
Shares to the Official List of the UK Listing Authority and to
trading on the London Stock Exchange's market for listed securities
("Admission"). The New Shares will rank pari passu with the
Company's existing ordinary shares and Admission is expected to
occur at 8.00am on 16 January 2019.
Following the allotment of the New Shares, it is expected that
the total number of shares in issue will be 2,398,085,921 (none of
which will be held in treasury) and that, accordingly, the total
number of voting rights of the Company will be 2,398,085,921.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).
This interim dividend is 100% ordinary dividend (non-PID).
Forms to register for gross PIDs (on future interim dividends)
are available on the Company's website. Please click here for PID
Forms.
-ENDS-
For more information, please contact:
Assura plc Tel: 01925 420660
Orla Ball
David Purcell
Edelman Tel: 0203 047 2546
John Kiely
Rob Yates
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices,
is a UK REIT and long-term investor in and developer of primary
care property. The company, headquartered in Warrington, works with
GPs, health professionals and the NHS to create innovative property
solutions in order to facilitate delivery of high quality patient
care in the community. At 30 September 2018, Assura's property
portfolio was valued at GBP1,843 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DIVGMGMMNMLGLZM
(END) Dow Jones Newswires
January 14, 2019 02:00 ET (07:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2024 to May 2024
Assura (LSE:AGR)
Historical Stock Chart
From May 2023 to May 2024